TORNTPHARM — Torrent Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.50tn
- IN₹1.72tn
- IN₹139.80bn
Annual cashflow statement for Torrent Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 12,259 | 18,472 | 23,521 | 26,728 | 28,722 |
| Depreciation | |||||
| Non-Cash Items | 6,878 | 2,307 | 1,857 | 2,011 | 1,825 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7,729 | -3,574 | -800 | -10,838 | -11,509 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 18,030 | 24,270 | 32,661 | 25,851 | 30,227 |
| Capital Expenditures | -2,026 | -5,739 | -4,328 | -6,119 | -6,774 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 59.4 | -18,414 | 2,649 | 718 | -120,350 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,966 | -24,153 | -1,679 | -5,401 | -127,124 |
| Financing Cash Flow Items | -2,577 | -3,030 | -3,710 | -2,622 | -4,275 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -17,811 | 774 | -27,796 | -22,980 | 101,506 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1,742 | 1,101 | 3,266 | -2,617 | 5,437 |